The Geopolitics of Vaccine Distribution

Inoculations are a welcome development, but the public should temper its excitement.

By
Alex Berezow
-
4861

The American pharmaceutical firm Pfizer, in collaboration with German firm BioNTech, surprised the world when it announced that its coronavirus vaccine showed 90 percent efficacy in preventing COVID-19. Days later, another American firm called Moderna announced that its vaccine was nearly 95 percent effective. And shortly after that, AstraZeneca announced that its vaccine was 62 […]

This article is for subscribers only

Join thousands of readers who rely on GPF for clear-eyed geopolitical analysis.

$79 per year Save 27% vs. monthly
✓Full access to all daily analysis & forecasts
✓George Friedman's geopolitical insights
✓2026 Forecast & Special Collection on the Middle East
✓100% reader-supported
Subscribe Now

30-day money-back guarantee

Already a subscriber? Log in

Alex Berezow
Alex Berezow
https://geopoliticalfutures.com/author/aberezow
Alex Berezow joins Geopolitical Futures to analyze the impact of science, technology, and public health on geopolitics. Dr. Berezow is a prolific science writer who has written over 1,000 articles, many of which appeared in major news outlets. He is also a monthly columnist for the Puget Sound Business Journal and a member of the USA Today Board of Contributors. Currently, Dr. Berezow is also Vice President of Scientific Communications at the American Council on Science and Health, a consumer advocacy non-profit whose mission is to debunk “junk science,” promote evidence-based policy, and separate exaggerated health scares from legitimate health threats. He is also a Non-Resident Fellow at the Council on Strategic Risks. Previously, he was founding editor of RealClearScience (of the RealClearPolitics family of websites), and he served as assistant editor of RealClearWorld, where he specialized in European affairs. Dr. Berezow holds a PhD in microbiology from the University of Washington.

RELATED ARTICLESMORE FROM AUTHOR